Portrazza
Generic: necitumumab
- Manufacturer
- Eli Lilly
- NDC
- 0002-7716
- RxCUI
- 1723745
- Route
- INTRAVENOUS
- ICD-10 indication
- C34.90
Affordability Check
How much will you actually pay for Portrazza?
In 30 seconds, see every legitimate way to afford Portrazza — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About Portrazza
What is this medication?
Portrazza is a prescription medication used to treat a specific type of lung cancer called metastatic squamous non-small cell lung cancer. It is specifically indicated for patients who have not previously received chemotherapy for their metastatic disease. This drug belongs to a class of medications known as epidermal growth factor receptor inhibitors and is administered through an intravenous infusion by a healthcare professional.
The medication is typically prescribed in combination with two other chemotherapy drugs, gemcitabine and cisplatin. It works by targeting and binding to the epidermal growth factor receptor on the surface of certain cancer cells, which helps to interfere with the growth and spread of the tumor. Portrazza is not indicated for the treatment of non-squamous non-small cell lung cancer, and its use is limited to the squamous subtype.
Copay & patient assistance
Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for necitumumab.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup Portrazza →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for necitumumab →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
Related drugs
EVEROLIMUS
Treats same condition · Everolimus
AVMAPKI FAKZYNJA CO-PACK
Treats same condition · avutometinib potassium and defactinib hydrochloride
Fludeoxyglucose F18
Treats same condition · Fludeoxyglucose F18
Pilocarpine Hydrochloride
Treats same condition · Pilocarpine Hydrochloride
TEPADINA
Treats same condition · THIOTEPA
AVGEMSI
Treats same condition · Gemcitabine
CLENPIQ
Treats same condition · SODIUM PICOSULFATE, MAGNESIUM OXIDE, and ANHYDROUS CITRIC ACID
Niva Thyroid
Treats same condition · thyroid, porcine
Kisunla
Treats same condition · donanemab-azbt
AVODART
Treats same condition · dutasteride
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.